Extranodal involvement is extremely common in patients with ALK+ALCL with the involvement rates of 26% for the skin, 14% for the bones, 15% for the soft tissues, 12% for the lungs, and 8% for the liver (2, 6–8). This evidence concerns the gene ALK and anaplastic large cell lymphoma.